Akebia Therapeutics, Inc. (AKBA) financial statements (2021 and earlier)

Company profile

Business Address 245 FIRST STREET
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:269148322318260139109
Cash and cash equivalents229147105701875033
Short-term investments 0217248738976
Other undisclosed cash, cash equivalents, and short-term investments40 0 000
Receivables2739173434 0
Inventory, net of allowances, customer advances and progress billings61116114    
Inventory61116114    
Other undisclosed current assets157166221
Total current assets:371310468358296141110
Noncurrent Assets
Operating lease, right-of-use asset2729
Property, plant and equipment91084310
Long-term investments and receivables      40
Long-term investments      40
Intangible assets, net (including goodwill)199346383    
Goodwill555555    
Intangible assets, net (excluding goodwill)144291328    
Deferred costs      1
Other noncurrent assets38761372110
Other undisclosed noncurrent assets     0(41)
Total noncurrent assets:2734625286421
TOTAL ASSETS:644771997364300143111
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1721681945932129
Accounts payable4139437222
Accrued liabilities1311291515230105
Employee-related liabilities      2
Deferred revenue1540
Debt  15    
Postemployment benefits liability      0
Deferred revenue and credits8582  
Contract with customer, liability57
Other undisclosed current liabilities      (2)
Total current liabilities:187208266144114127
Noncurrent Liabilities
Long-term debt and lease obligation121103     
Long-term debt, excluding current maturities9676     
Operating lease, liability2528
Liabilities, other than long-term debt86638810111800
Deferred revenue and credits101118  
Deferred revenue2533
Contract with customer, liability56
Deferred rent credit  3
Other liabilities6130300000
Other undisclosed noncurrent liabilities227    
Total noncurrent liabilities:2091689510111800
Total liabilities:397376361245232127
Stockholders' equity
Stockholders' equity attributable to parent, including:24839563611968131104
Common stock000    
Treasury stock, value     (0)(0)
Additional paid in capital1,4251,1891,151494365293205
Accumulated other comprehensive income (loss)0 (0)(0)(0)(0)(0)
Accumulated deficit(1,178)(794)(514)(374)(297)(161)(101)
Other undisclosed stockholders' equity attributable to parent      0
Total stockholders' equity:24839563611968131104
TOTAL LIABILITIES AND EQUITY:644771997364300143111

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues2953352081782 1
Revenue, net1782 1
Cost of revenue(296)(145)(8)    
Cost of goods and services sold(180)(109)(6)    
Gross profit:(1)1902001782 1
Operating expenses(376)(476)(378)(258)(138)(62)(38)
Other undisclosed operating loss      (1)
Operating loss:(376)(286)(178)(80)(136)(62)(38)
Nonoperating income (expense)2(1)0010 
Investment income, nonoperating    1  
Other nonoperating income (expense)2(1)00(0)0 
Loss from continuing operations before equity method investments, income taxes:(375)(287)(178)(80)(136)(61)(38)
Other undisclosed income (loss) from continuing operations before income taxes(9)16    
Loss from continuing operations before income taxes:(383)(286)(172)(80)(136)(61)(38)
Income tax benefit 728    
Net loss:(383)(280)(144)(80)(136)(61)(38)
Other undisclosed net income attributable to parent   3 11
Net loss attributable to parent:(383)(280)(144)(77)(136)(61)(37)
Preferred stock dividends and other adjustments      (87)
Other undisclosed net loss available to common stockholders, basic      (0)
Net loss available to common stockholders, diluted:(383)(280)(144)(77)(136)(61)(124)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(383)(280)(144)(80)(136)(61)(38)
Other comprehensive loss      (0)
Comprehensive loss:(383)(280)(144)(80)(136)(61)(38)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0002(0)01
Comprehensive loss, net of tax, attributable to parent:(383)(279)(143)(77)(136)(61)(37)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: